68 related articles for article (PubMed ID: 27460008)
61. Taspine derivative 12k suppressed A549 cell migration through the Wnt/β-catenin and EphrinB2 signaling pathway.
Dai B; Ma Y; Yang T; Wang W; Zhang Y
Biomed Pharmacother; 2017 Mar; 87():102-109. PubMed ID: 28049091
[TBL] [Abstract][Full Text] [Related]
62. Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis via suppression of EphrinB2 and related signaling pathways.
Liu R; Yu R; Cui Y; Fan M; Wang B; Zhang Y
Acta Pharm; 2019 Sep; 69(3):423-431. PubMed ID: 31259732
[TBL] [Abstract][Full Text] [Related]
63. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
64. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
[TBL] [Abstract][Full Text] [Related]
65. Antitumor activity of taspine by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo.
Zhang Y; Zheng L; Zhang J; Dai B; Wang N; Chen Y; He L
Planta Med; 2011 Nov; 77(16):1774-81. PubMed ID: 21614750
[TBL] [Abstract][Full Text] [Related]
66. A taspine derivative supresses Caco-2 cell growth by competitively targeting EphrinB2 and regulating its pathway.
Dai B; Wang W; Ma Y; Liu R; Zhang Y
Oncol Rep; 2016 Sep; 36(3):1526-34. PubMed ID: 27460008
[TBL] [Abstract][Full Text] [Related]
67. Targeting the PI3K/Akt/mTOR pathway in ocular neovascularization.
Sasore T; Reynolds AL; Kennedy BN
Adv Exp Med Biol; 2014; 801():805-11. PubMed ID: 24664774
[TBL] [Abstract][Full Text] [Related]
68.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
